RNA, U6 small nuclear 624, pseudogene (RNU6-624P)

RNU6-624P (RNA, U6 small nuclear 624, pseudogene) is a processed pseudogene derived from U6 small nuclear RNA, a highly conserved non-coding RNA that functions in the spliceosome complex required for pre-mRNA splicing in eukaryotes[1][3]. U6-derived pseudogenes are common in the human and vertebrate genome, representing inactive, non-functional genomic copies that do not produce functional U6 snRNA or proteins[3]. The gene does not act as a receptor, enzyme, transporter, or any classical druggable target. There are no known roles for RNU6-624P specifically in disease, drug interaction, or as a clinical biomarker, and there is no evidence it is misclassified, but as a pseudogene, it lacks direct biological or therapeutic importance. Further Context and Explanation: Is the entry incorrect? The name and abbreviation are correct, but RNU6-624P is a pseudogene, not a receptor, enzyme, or therapeutic target, and thus is not "a target" in the pharmacological sense. If your intent was to find structured target/biological/therapeutic information, this entry is not correct as a drug target[3][4]. Role of U6 snRNA and its pseudogenes: Canonical U6 snRNA is a core spliceosome component engaging in post-transcriptional splicing of pre-mRNA[1][3]. Its pseudogenes—including RNU6-624P—do not supply this function. Some other pseudogenes have noted regulatory or disease involvement[4], but no specific data are found for RNU6-624P. Pseudogenes in general can serve as "competing endogenous RNAs" to sponge miRNA and indirectly impact gene regulation[4], but no evidence supports RNU6-624P as having such a function.

Other names

RNU6-624PU6 snRNA pseudogene 624RNA, U6 small nuclear pseudogene 624